The sudden increase in COVID-19 cases is putting high pressure on healthcare services
worldwide. At this stage, fast, accurate and early clinical assessment of the disease severity is …

Persulfate-based nonradical oxidation processes (PS-NOPs) are appealing in wastewater
purification due to their high efficiency and selectivity for removing trace organic contaminants …

Abstract Treatment of pediatric acute lymphoblastic leukemia (ALL) is based on the concept
of tailoring the intensity of therapy to a patient's risk of relapse. To determine whether gene …

Background Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is
characterized by a gene-expression profile similar to that of BCR–ABL1–positive ALL, …

Early T-cell precursor acute lymphoblastic leukaemia (ETP ALL) is an aggressive malignancy
of unknown genetic basis. We performed whole-genome sequencing of 12 ETP ALL cases …

Background Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic
leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high …

Background Prophylactic cranial irradiation has been a standard treatment in children with
acute lymphoblastic leukemia (ALL) who are at high risk for central nervous system (CNS) …

Background About a fifth of children with acute T-lymphoblastic leukaemia (T-ALL) succumb
to the disease, suggesting an unrecognised biological heterogeneity that might contribute to …

Background Childhood acute lymphoblastic leukemia (ALL) is curable with chemotherapy
in approximately 80 percent of patients. However, the cause of treatment failure in the …

Genetic alterations that activate NOTCH1 signaling and T cell transcription factors, coupled
with inactivation of the INK4/ARF tumor suppressors, are hallmarks of T-lineage acute …